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Summary 
The exquisite sensitivity of thymocytes to steroid- 
induced apoptosis, the steroidogenic potential of thy- 
mic epithelial cells, and the ability of steroid synthesis 
inhibitors to enhance antigen-specific deletion of thy- 
mocytes in fetal thymic organ cultures suggest a role 
for glucocorticoids in thymocyte development. To ad- 
dress this further, transgenic mice that express anti- 
sense transcripts to the glucocorticoid receptor (GR) 
specifically in immature thymocytes were generated. 
The consequent hyporesponsiveness of thymocytes 
to glucocorticoids was accompanied by a reduction 
in thymic size, primarily owing to a decrease in the 
number of CD4+CD8+ cells. While an enhanced sus- 
ceptibility to T cell receptor (TCR)-mediated apoptosis 
appeared to be partially responsible for this reduction, 
thymocyte loss could also be detected before thymo- 
cytes progressed to the CD4+CD8+ TCRa8-expressing 
stage. These results suggest that glucocorticoids are 
necessary for survival and maturation of thymocytes, 
and are consistent with a role for steroids in both the 
transition from CD4CD8- to CD4+CD8+ cells and the 
survival of CD4+CD8+ cells stimulated via the TCR. 
Introduction 
Glucocorticoids play an essential role in the embryonic 
development of many tissues, including the palate, retina, 
and liver (Ballard, 1979). During fetal and perinatal devel- 
opment, glucocorticoids influence the expression of gluco- 
neogenic enzymes such as tyrosine aminotransferase in 
the liver (Cole et al., 1993) and glutamine synthetase in 
the retina (Ben-Dror et al., 1993; Zhang et al., 1993). An 
inability to up-regulate gluconeogenic hepatic enzymes in 
a steroid-responsive fashion results in neonatal lethality 
(DeFrancoet al., 1991; Ericksonet al., 1968), emphasizing 
the importanceof glucocotticoidsfor normal development. 
While glucocorticoids certainly play an important role 
in embryogenesis, little is known about the role of steroids 
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in normal thymocyte development. All lymphocytes ex- 
press functional glucocorticoid receptors (GRs) (Plaut, 
1987), and glucocorticoid stimulation of thymocytes re- 
sults in the transcription of many steroid-responsive genes 
(Baughman et al., 1991, 1992). Immature thymocytes are 
exquisitely sensitive to glucocorticoid-induced apoptosis 
and can be killed by glucocorticoid levels achieved during 
stress (Wyllie, 1980; Cohen, 1992; Selye, 1936; Dough- 
erty, 1952; Gruber et al., 1994). Adrenalectomy of adult 
animals leads to thymic hypertrophy, suggesting that even 
physiologic levels of glucocorticoids are involved in the 
maintenance of normal thymic cellularity (Jaffe, 1924). 
Since the vast majority of immature thymocytes produced 
in the thymus die, it has been speculated that endogenous 
glucocorticoids are at least in part responsible for eliminat- 
ing the thymocytes that die by “neglect;” those cells ex- 
pressing T cell receptors (TCRs) of insufficient avidity to 
allow them to undergo either positive or negative selection 
(Sprent et al., 1988; Cohen, 1992). In contrast, the finding 
that albino mutant mice deficient in their ability to up- 
regulate gluconeogenic hepatic enzymes in a steroid- 
responsive fashion have abnormally small thymi (De- 
Franc0 et al., 1991; Erickson et al., 1968) suggests that 
glucocorticoids may also play a positive role in thymocyte 
development. 
In addition to their ability to induce thymocyte apoptosis 
directly, glucocorticoids influence thymocytes and T cells 
by modifying the biological responses to signals delivered 
via the TCR. For example, glucocorticoids can interfere 
with signaling through an incompletely understood inter- 
action between the GR and activation-induced transcrip- 
tion factors such as AP-1 and NFAT, altering the regulation 
of the interleukin 2 (IL-2) promoter (Vacca et al., 1992; 
Northrop et al., 1992). Of particular interest is that while 
both glucocorticoids and TCR-mediated activation inde- 
pendently cause apoptotic death of T cell hybridomas and 
immature thymocytes, simultaneous stimulation with both 
resultsincellsurvival(Zacharchuketal., 1990,199l; lwata 
et al., 1991). Thus, while exposureof unstimulated thymo- 
cytes to glucocorticoids will most likely result in apoptotic 
death, glucocorticoids can paradoxically rescue thymo- 
cytes from activation-induced cell death. Such results 
prompted us to examine the role that glucocorticoids might 
play in thymocyte development. Consistent with an im- 
portant role for steroids in this process, a subset of thymic 
epithelial cells was found to express steroidogenic en- 
zymes and was capable of synthesizing steroids (Vacchio 
et al., 1994). Furthermore, inhibition of steroid synthesis in 
day 17 fetal thymic organ culture resulted in the enhanced 
deletion of thymocytes in response to TCR ligation (Vac- 
chio et al., 1994), demonstrating that the endogenously 
produced steroids can antagonize activation-induced cell 
death. 
To explore the role of glucocorticoids in thymocyte de- 
velopment in vivo, we have created transgenic mice in 
which expression of antisense transcripts to the GR was 
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specifically targeted to immature thymocytes. Thymocytes 
from these animals have reduced levels of GR and are 
hyporesponsive to glucocorticoids. The analysis of thymo- 
cyte development in these animals suggests that glucocor- 
ticoids may be important at several stages in T cell on- 
togeny. 
Results 
Generation of Transgenic Mice Expressing Antisense 
Transcripts to the GR in Thymocytes 
Transgenic mice were created in which antisense tran- 
scripts to the GR were expressed specifically in developing 
thymocytes. A tissue-targeted rather than a conventional 
gene knockout approach was chosen to reduce the possi- 
bility that thymocyte development might be indirectly af- 
fected by loss of glucocorticoid-responsiveness in other 
tissues. These transgenic animals, termed GR-TKO mice, 
expressed a fragment of the 3’ untranslated region of the 
rat GR in an antisense orientation under the control of the 
proximal lck promoter, which is active predominantly in 
immature thymocytes (Garvin et al., 1990). Although anti- 
sense approaches are unlikely to abolish expression of 
the targeted protein completely, the identical GR fragment 
expressed in an antisense orientation under the control 
of a neurofilament promoter has been used successfully to 
down-regulate GR protein levels in the brainsof transgenic 
mice, consequently disrupting the normal hypothalamus- 
pituitary-adrenal axis (Pepin et al., 1992). Furthermore, 
since thymocytes express relatively low levels of GR pro- 
tein (approximately 6000 receptors/cell; Duval et al., 1976) 
and GRs are limiting for the induction of glucocorticoid- 
induced apoptosis in T cell lymphomas that express at 
least twice as many GRs (Huet-Minkowski et al., 1962; 
Dieken and Miesfeld, 1992), it seemed likely that even an 
incomplete reduction in GR levels, such as the 34%-500/o 
decrease found in the brains of animals expressing the 
GR antisense (Pepin et al., 1992), would alter the steroid 
sensitivity of thymocytes. 
Three founder animals carrying the GR antisense 
transgene were identified. One female founder did not pro- 
duce offspring and was subsequently found to have a poly- 
cystic uterus. Hemizygous offspring of the remaining two 
male transgenic mice had similar phenotypic characteris- 
tics in that thymocyte number was dramatically reduced, 
primarily owing to a decrease in the number of CD4+CD6+ 
cells (Figure 1). The detailed analyses presented below 
were performed with GR-TKO 1 .l, the line that exhibited 
the more profound phenotype. Examination of RNA from 
various tissues of homozygous GR-TKO mice (GR-TKO 
+It) revealed that the transgene was expressed predomi- 
nantly in the thymus (Figure 2). As previously observed 
(Garvin et al., 1990) the Ick promoter also drove low level 
transcript expression in the spleen, but no specific tran- 
scripts were detected in any other tissue analyzed. Fur- 
thermore, serum corticosterone levels were not elevated 
in the GR-TKO +/+ mice (data not shown), providing physi- 
ological evidence that the targeted transgene had no effect 
on nonthymic tissues. 
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Figure 1. Thymic Phenotype of Hemizygous Offspring of Two Indepen- 
dent GR-TKO Founder Mice 
Thymocytesfrom nontransgenicand hemizygousoffspring of GA-TKO 
founder mice were stained with phycoerythrin-labeled anti-CD4 and 
biotinylated anti-CD6 (detected with Cy-chrome) and analyzed by flow 
cytometry with a FACScan. Absolute numbers of thymocyte subpopu- 
lations (2 SEM) were obtained from 16 nontransgenic, 9 GR-TKO 
1.1, and 9 GR-TKO 1.2 mice (6-l 0 weeks of age). 
Antisense Transcripts to the GR Down-Regulate 
GR Expression 
Several approaches were used to assess the effect of the 
antisense transgene on thymocyte GR expression. As 
judged by Northern blot analysis, thymic GR mRNA in 
GR-TKO +/+ mice was reduced approximately 50% com- 
pared with nontransgenic age-matched controls (Figure 
3A). Consistent with the tissue distribution of transgene 
expression, GR mRNA was not down-regulated in spleno- 
cytes (Figure 38). lmmunoblot analysis of cytoplasmic ex- 
tracts with a monoclonal anti-GR antibody revealed that 
GR levels were substantially reduced in thymocytes of 
Figure 2. Tissue Distribution of Transgenic Transcripts in GR-TKO 
Mice 
RNA was extracted from the indicated tissues of GR-TKO +/+ mice. 
Total RNA (10 ng) was subjected to Northern blot analysis and probed 
with a cDNA sequence containing the 3’ untranslated region of the 
rat GR. 
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Figure 3. Quantitation of mRNA and Protein Expression in GR-TKO 
Mice 
(A) Total RNA (10 pg) from nontransgenic -I- or GR-TKO +/+ thymo- 
cytes or(B) splenocytes was subjected to Northern blot analysis using 
a fragment of the coding region of the mouse GR cDNA. The blot was 
then reprobed with a GAPDH probe to control for loading. Cytoplasmic 
extracts were prepared from thymocytes and equivalent amounts of 
cytoplasmic protein (46 pg for the GR blot, 83 pg for the Lck blot) were 
electrophoresed on a 9% SDS-polyacrylamide gel. After transfer, the 
blots were probed with either (C) the monoclonal anti-GR antibody, 
BUGR-2, or (D) anti-Lck rabbit antiserum 688, followed by 1251-pro- 
tein A. 
GR-TKO +I+ compared with -I- control mice (43% as 
determined by Phosphorlmager, comparing extracts from 
six -I- mice and four GR-TKO +I+ mice) (Figure 3C). 
Comparable results (34%-50% decreases in GR levels) 
were obtained in brains from transgenic mice expressing 
the GR antisense fragment under the control of the neuro- 
filament promoter and which, as mentioned above, re- 
sulted in profound physiological effects (Pepin et al., 
1992). In contrast, no difference was found in levels of 
Lck, indicating the specificity of the GR antisense and 
demonstrating that the Ick proximal promoter in the 
transgene did not secondarily alter the expression of the 
endogenous gene (Figure 3D). 
Down-Regulation of GR Reduces Steroid Sensitivity 
of GR-TKO Thymocytes 
The GR is a ligand-activated transcription factor that regu- 
lates the expression of many steroid-responsive genes 
(Beato, 1989). To determine whether the reduction in GR 
levels in GR-TKO mice was sufficient to alter glucocorti- 
coidinduced gene transcription, thymocytesfrom -I-- and 
GR-TKO +I+ mice were transfected with a luciferase ex- 
pression construct under the control of two consensus 
glucocorticoid response elements (GREs). The glucocorti- 
coiddependent induction of luciferase expression was ap- 
proximately Z&fold higher in the nontransgenic thymocytes 
than in thymocytes from GR-TKO +I+ mice (Figure 4), 
indicating that glucocorticoid-induced gene transcription 
is impaired in the transgenic animals. Cotransfection with 
a CMV-P-galactosidase control plasmid revealed that 
transfection efficiency and transcriptional activity were 
similar in nontransgenic and transgenic thymocytes (Fig- 
ure 4, legend). 
These results are likely to represent a valid comparison 
between thymocytes from control and GR-TKO mice, be- 
cause it has been shown that, using DEAE-dextran, it is 
the steroid-sensitive CD4+CD8+ cells that primarily ex- 
press plasmid DNA after transient transfections of thymo- 
cytes (Novak et al., 1992), and CD4+CD8+ cells comprise 
the majority of thymocytes in both -I- and GR-TKO +I+ 
mice (see below). Furthermore, the differential sensitivity 
of thymocytes to glucocorticoid-induced apoptosis has 
been ascribed lo up-regulation of Bcl-2 in mature steroid- 
resistant cells (Nakayama et al., 1993), and does not ap- 
pear to reflect an alteration in the ability of the GR to acti- 
vate genes transcriptionally. Nonetheless, it is formally 
possible that the differences noted in glucocorticoid- 
induced luciferase activity could be due to a skewing of 
thymocytes toward relatively glucocorticoid-insensitive 
populations in the transgenic mice with unequal uptake 
of plasmid DNA. To confirm independently the observed 
alteration in steroid-induced transcriptional activation, the 
sensitivity of CD4+CD8+ thymocytes to glucocorticoid- 
induced apoptosis in -I- and GR-TKO mice was deter- 
mined. Thymocytes from -I- or GR-TKO +I+ mice were 
placed in suspension culture in the presence of increasing 
amounts of corticosterone. After 11 hr, the cells were har- 
vested and analyzed by three-color flow cytometry to de- 
termine what fraction of CD4+CD8+ cells were dead or 
dying. Whereas steroid-induced death of CD4+CD8+ cells 
Expt. 1 Expt. 2 
0.3 1 3 _ 0.1 1 
uM corticosterone 
Figure 4. Induction of a GR-Regulated Reporter Gene in Control and 
GR-TKO +I+ Mice 
Thymocytes from four nontransgenic (-I-) or 13 GR-TKO +I+ mice 
were transiently transfected with 15 pg of GRE-LUC and 1 r(g of a 
CMV-P-galactosidase construct as an indicator of transfection effi- 
ciency. Fold induction over activity seen in cells cultured without corti- 
costerone is shown. In experiment 1, relative light units for luciferase 
expression measured in unstimulated cultures were 340 (f 23) and 
274 ( f 38) in -I- and GR-TKO +/+ thymocytes, respectively, and 
106120 ( f 3951) and 68514 ( f 1069) for P-galactosidase. In experi- 
ment 2, relative light units in nontransgenic thymocytes were 359 and 
390 in GR-TKO +I+ mice, while p-galactosidase activities were 107708 
and 136778, respectively. 
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from -I- mice was initially detected at a concentration 
of 0.3 PM corticosterone, death of CD4+CD8+ cells from 
GR-TKO +I+ mice was not observed until a 3-fold higher 
concentration of corticosterone was used (Figure 5). The 
fraction of CD4+CD8+ cells undergoing glucocorticoid- 
induced apoptosis reached a plateau of - 30% for control 
thymocytes, compared with 5%-80/o for GR-TKO +I+ 
CD4+CD8+ thymocytes. A similar analysis of CD4+CD8- 
cells revealed less steroid-induced death, and no differ- 
ences between -I- and GR-TKO +/+ mice (data not 
shown). Together, these data indicate that the reduction 
in GR levels in GR-TKO +I+ mice resulted in an impairment 
of glucocorticoidinduced gene transcription and a re- 
duced sensitivity to glucocorticoid-induced apoptosis of 
CD4+CD8+ thymocytes. 
Thymocyte Development Is Altered in GR-TKO Mice 
Hyporesponsiveness to glucocorticoids was accompanied 
by a dramatic reduction in thymocyte number in GR-TKO 
+I+ mice (- 10% of that found in age- and sex-matched 
-I- mice). CD4/CD8 profiles revealed a reduced fre- 
quency of CD4+CD8+ cells, with a compensatory increase 
in the frequency of CD4-CD8- cells (Figure 6A). The abso- 
lute number of CD4+CD8+ cells was reduced the most 
(-950/o), followed closely by decreases in the number of 
CD4+CD8- and CD4-CD8+ cells (-80%) (Figure 66). In 
contrast, the number of CD4-CD8- cells was comparable 
in -I- and GR-TKO +I+ mice. The level of transgene ex- 
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Figure 5. Induction of CD4’CDS’Thymocyte Apoptosis by Glucocorti- 
coids in Control and GR-TKO +I+ Mice 
Thymocytes from individual mice were placed in suspension culture 
with the indicated concentrations of corticosterone. After 11 hr, cells 
were harvested and stained with phycoerythrintonjugated anti-CD4 
and fluorescein-conjugated anti-CD6 antibodies. PI was added to in- 
tact cells to identify dead or dying cells with compromised membrane 
integrity, and the cells were analyzed by flow cytometry on the 
FACScan. After analysis, gates were set around the CD4+CD6+ cells 
and the percentage of cells staining with PI was determined. The per- 
centage of PI’ cells in experimental wells minus that observed in me- 
dium-only control wells is shown. The percent PI’ cells in medium-only 
control wells was 7.3% for -I- thymocytes and 16.6% for GR-TKO 
+I+ thymocytes. 
pression was critical for the phenotype of GR-TKO mice, 
since hemizygous animals had cell numbers that were 
intermediate between the nontransgenic and homozygous 
mice (Figure 6B). Consistent with the observed changes in 
the fractional representation of CD4+CD8+ and CD4-CD6- 
cells, there was a relative decrease in the percentage of 
cells expressing intermediate levels of TCR and an in- 
crease in cells expressing low TCR levels (data not 
shown). Significant numbers of mature peripheral T cells 
were found in the spleens of GR-TKO +I+ animals (55%- 
72% of normal T cell number in mice 2-6 weeks of age), 
suggesting that the small numbers of CD4+CD8- and 
CD4-CD8+ T cells produced in the thymus accumulate 
over time in peripheral tissues. 
Increased Frequency of Thymocyte Apoptosis 
in GR-TKO Mice 
To determine whether increased cell death contributed to 
the reduction in CD4+CD8+ cell number in GR-TKO mice, 
freshly isolated thymocytes were stained with propidium 
iodide and analyzed by flow cytometry. The frequency of 
positively staining (i.e., dead) cells was 2-to 3-fold higher 
in the GR-TKO +I+ mice than in the -I- controls (data 
not shown). Apoptotic cell death was directly measured 
with a modified TUNEL assay in which nicked DNA is fluo- 
rescently labeled (Gold et al., 1993). Few (<3%) cells with 
fragmented DNA were detected in preparations made 
from -I- thymi, while almost 10% of freshly isolated thy- 
mocytes from GR-TKO +I+ mice had fragmented their 
DNA (Figure 7). When analyzed by three-color flow cyto- 
metry(CD4versusCD8versusTUNEL), the majorityof the 
dying cells were found to be CD4+CD8+ (data not shown). 
Therefore, in the absence of any external manipulation, 
a sizable fraction of CD4+CD8+ thymocytes undergo 
apoptosis in GR-TKO +I+ mice. 
If the increased spontaneous rate of CD4+CD8+ cell 
apoptosis in GR-TKO +/+ mice was due to the failure of 
steroids to antagonize activation-induced death, it would 
be predicted that thymocytes from these animals would 
be highly susceptible to TCR-mediated deletional stimuli. 
Anti-TCR antibodies mimic high avidity TCR-ligand inter- 
actions, resulting in the apoptotic death of CD4+CD8+ thy- 
mocytes (Smith et al., 1989). Therefore, various concen- 
trations of anti-TCR antibody were added to fetal thymic 
organ cultures of thymi from normal or GR-TKO +/+ mice. 
Anti-TCRl3 antibodies caused a significant reduction in the 
recovery of CD4+CD8+ thymocytes from control mice only 
at relatively high concentrations (22 pg/ml) (Figure 8). In 
contrast, much lower antibody concentrations caused a 
significant loss of CD4+CD8+ GR-TKO +I+ thymocytes, 
with deletion noted with as little as 0.02 kg/ml (Figure 8). 
Therefore, CD4+CD8+ thymocytes from GR-TKO +I+ mice 
are abnormally sensitive to TCR-mediated deletion. 
Requirement for Glucocotticoids in Early 
Thymocyte Development 
To determine how lack of steroid responsiveness affects 
T cell development early in ontogeny, the thymic pheno- 
type of normal and GR-TKO mice fetal mice was com- 
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Figure6. GR-TKO Mice Have Greatly Reduced 
Number of Thymocytes Due Primarily to De- 
creases in the CDQCDB’ and Single-Positive 
Populations 
Thymocytes from nontransgenic -I-, hemizy- 
gous GR-TKO +I-, and homozygous GR-TKO 
+I+ mice were stained with phycoerythrin- 
labeled antiCD4. biotinylated anti-CD8 (de 
tected with Cy-chrome), and fluoroscein- 
labeled H57 (anti-TCR 6) and analyzed by flow 
cytometry on the FACScan. 
(A) CD4/CD8 profile of control -I- (left) and 
GR-TKO +I+ (right) thymocytes. 
(6) Absolute numbers of thymocyte subpopu- 
lations obtained from 12 -I-, 4 +I-. and 16 
+I+ mice (5-7 weeks of age). Each symbol rep 
resents cell recovery from one mouse. 
Figure 7. Spontaneous Thymocyte Death in 
Control and GR-TKO +I+ Mice 
Thymocytes freshly harvested from non- 
transgenic -I- and GR-TKO +I+ mice were 
subjected to a modified in situ nick translation 
assay using fluorescein-dUTP and DNA poly- 
merase. Cells were visualized and counted by 
phase microscopy (A, left) and the frequency 
of fluorescent cells was determined by fluores- 
cent microscopy (A, right). A minimum of 375 
500 cells were counted in each experiment; 
the actual numbers and the arithmetic mean 
(* SEM) of three experiments are shown in (B). 
non-transgenic (-/-) GR-TKO (+/+) 
total cells labeled cells % labeled cells total cells labeled cells % labeled ceR5 
Expt.1 552 7 1.3 593 61 10.3 
Fxpt. 2 416 12 2.9 374 29 7.8 
apt. 3 506 19 3.8 399 41 10.3 - - 
Mean: 491 13 2.7(* 0.73) 455 44 9.5 (k 0.83) 
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Figure 8. TCR-Mediated Thymocyte Death in Control and GR-TKO 
+I+ Mice 
Individual lobes from fetal thymi (day 17.5) were cultured for 24 hr. 
Lobes were teased apart, viable cells counted in the presence of trypan 
blue, and the fraction of cells that were CD4+CD6+ was determined. 
Each point represents data obtained from 4-7 individual lobes. Thymic 
lobes from nontransgenic mice cultured in medium alone contained 
an average of 1.6 x lo8 cells and were 84.5% CD4CD8’; GR-TKO 
+/+ thymic lobes had an average of 2.9 x lo5 cells and were 32.3% 
CD4’CDV. 
pared. During day 14 and day 15 of fetal development, 
when all of the thymocytes are CD4CD8CD3-, cell recov- 
ery from nontransgenic and GR-TKO +/+ mice was identi- 
cal (Figure 9) as were the subsets defined by CD44 and 
CD25 (data not shown). On fetal day 16, however, cell 
recovery from GR-TKO +I+ thymi was approximately 50% 
of that from -I- thymi. Furthermore, on fetal day 16 about 
20% of thymocytes from nontransgenic mice were 
CD4+CD8+, while only 8% of the GR-TKO +I+ thymocytes 
were CD4+CD8+ (data not shown). By fetal day 18, the 
reduction in cell recovery was comparable to that observed 
in adult animals, and the majority of this decrease could 
be accounted for by the loss of CD4+CD8+ cells (26.5 x 
IO4 in nontransgenic mice, 1.7 x lo4 in GR-TKO +/+ 
mice). These results suggest that glucocorticoids are im- 
portant during the proliferative phase that accompanies 
the transition from CD4-CD8- to CD4+CD8+ cells. 
Effect of Inhibition of Corticosterone Production 
on Early Thymocyte Development 
To confirm independently that glucocorticoids affect early 
fetal thymocyte development, a corticosterone synthesis 
inhibitor, metyrapone, was added to day 14 fetal thymic 
organ cultures. Previous studies showed that while a rela- 
tively low concentration of metyrapone (150 trg/ml) had 
no effect on fetal thymocyte development in organ culture, 
this concentration synergized with anti-TCR antibody to 
enhance TCR-mediated thymocyte deletion (Vacchio et 
al., 1994). To determine whether higher concentrations of 
metyrapone would affect thymocyte development in the 
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Figure 9. Analysis of Thymocyte Development during Fetal Ontogeny 
in GR-TKO +/+ Mice and Nontransgenic Mice 
Thymocytes from day 14, day 15, day 16, and day 16 fetal mice were 
harvested and counted. Absolute numbers of thymocytes obtained 
from day 14 (n = 6) day 15 (n = 1.5) day 16 (n = 14) and day 18 
(n = 12) nontransgenic mice and day 14 (n = 6) day 15 (n = 15), 
day 16 (n = 11) and day 18 (n = 7) from GR-TKO +/+ mice were 
obtained. The average cell recovery (2 SEM) are shown. 
absence of an exogenous stimulus, thymi were obtained 
from day 14 fetuses and cultured for 8 days in serum-free 
medium (to avoid exogenous steroids) in the absence or 
presence of a relatively high concentration of metyrapone 
(225 fig/ml). As shown in Figure 10, inhibition of corticoste- 
rone synthesis by the fetal thymus resulted in a substantial 
loss of both CD4+CD8+ cells and their CD4+CD8- and 
CD4-CD8+ progeny, but there was no decrease in the num- 
ber of CD4CD8- thymocytes. Importantly, the effect of 
metyrapone was specific, as cell recovery was largely re- 
stored by the addition of physiologic levels (1O-Q M) of free 
corticosterone. Therefore, it appears that glucocorticoid 
stimulation of thymocytes is essential for the expansion of 
CD4-CD8- thymocytes as they progress to the CD4+CD8+ 
stage in fetal thymic organ culture. These results are 
consistent with those obtained in the GR-TKO +/+ mice 
in which hyporesponsiveness to glucocorticoid stimula- 
tion resulted in inefficient transition from CD4-CD8- to 
CD4+CD8+ cells. 
Discussion 
The complex endocrine interactions between thymocytes, 
thymic epithelial cells, and thymic stromal cells are well 
documented (Hadden, 1992). While it has long been 
known that interleukins’and peptide hormones are pro- 
duced in the thymus, it has only recently been demon- 
strated that the thymus is also a site of glucocorticoid syn- 
thesis(Vacchioet al., 1994).Theabilityof thymicepithelial 
cells to secrete glucocorticoids appears to be subject to 
regulatory control. Thymic epithelial cells and activated T 
cells have been proposed to secrete both adrenocortico- 
trophic hormone (ACTH) (Batanero et al., 1992), a peptide 
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Medium Metyrapone Metyrapone + 
Corticosterone 
Corticosterone 
Total 31.0 8.9 21.6 36.9 
CD4-CD% 3.2 5.5 6.3 6.2 
CDI+CDE+ 21.0 1.5 10.8 23.8 
CD4+CDB- 3.3 0.4 2.2 4.4 
CD4-CD8+ 2.5 1.5 2.3 2.5 
Figure 10. Effect of High Dose Metyrapone on Thymocyte Development 
Fetal day 14 thymi from BALB/c mice were cultured in the absence or presence of 225 Kg/ml metyrapone with or without 10m9 M corticosterone 
for 6 days. Recovered ceils were counted and analyzed by FACS for CD4 and CD8 expression. A flow cytometry profile of a representative thymus 
from each group is shown. Numbers below the figure represent the mean cell recovery for each group (n = 4). 
that potentiates steroid secretion by adrenal cells (Hanu- 
koglu et al., 1990), and corticotropin-releasing factor 
(CRF), a hormone that induces ACTH secretion (Aird et 
al., 1993). Since in vitro secretion of steroids by the thymus 
is enhanced by treatment with ACTH (Vacchio et al., 1994), 
it is possible that locally produced CRF and ACTH may 
participate in the regulation of glucocorticoid production 
in the thymus. 
It has been hypothesized that glucocorticoids might af- 
fect thymocyte development in a number of ways. The 
exquisite sensitivity of immature thymocytes to glucocorti- 
coidinduced apoptosis (Wyllie, 1980; Cohen and Duke, 
1984) led to the suggestion that steroids may serve to limit 
the number of neglected thymocytes (i.e., those thymo- 
cytes expressing TCRs of insufficient avidity to undergo 
either positive or negative selection) (Sprent et al., 1988; 
Cohen, 1992). In addition to their ability to induce 
apoptosis, glucocorticoids have also been shown to modu- 
late biological responses to TCR-mediated signaling 
(Vacca et al., 1992; Northrop et al., 1992; Zacharchuk 
et al., 1990, 1991; lwata et al., 1991), providing another 
mechanism by which glucocorticoids might influence thy- 
mocyte development. In particular, glucocorticoids and 
TCR occupancy, each of which independently can induce 
apoptosis in T cell hybridomas and immature thymocytes, 
antagonize one another when used simultaneously (Za- 
charchuk et al., 1990, 1991; lwata et al., 1991). Indeed, 
inhibition of steroid synthesis in fetal thymic organ culture 
results in so-called overdeletion of CD4+CD8+ thymocytes 
in response to TCR occupancy or ligation, supporting a 
model in which steroid stimulation plays a role in antigen- 
specific thymocyte cell selection (Vacchio et al., 1994). 
The data in the present report support another, unex- 
pected, role for glucocorticoids in thymocyte develop- 
ment. Expression of a GR antisense transgene in imma- 
ture thymocytes resulted in reduced GR expression and 
hyporesponsiveness to corticosteroids. Surprisingly, de- 
spite the potent thymotoxic effects of glucocorticoids, ste- 
roid hyporesponsiveness in GR-TKO +I+ mice was ac- 
companied by a substantial reduction in thymocyte 
number, particularly in the CD4+CD8+ subset. While over- 
all cell number was greatly decreased, the number of 
CD4CD8- cells was preserved. These results suggest 
that there is a requirement for glucocorticoids at, or subse- 
quent to, the CD4-CD8- to CD4+CD8+ transition. In previ- 
ous studies demonstrating the importance of steroids in 
antigen-specific thymocyte cell selection, steroid synthe- 
sis inhibitors were added to fetal thymic organ cultures 
and could, therefore, have indirectly altered thymocyte 
development by influencing steroid-responsive processes 
in nonthymocytes (Vacchio et al., 1994). Using this tar- 
geted antisense approach, however, it is clear that steroid 
stimulation of immature thymocytes themselves is re- 
quired for the development, maintenance, or both of nor- 
mal numbers of CD4+CD8+ cells. 
The decreased number of CD4’CD8+ cells in GR-TKO 
+I+ mice could be accounted for by a decreased rate of 
production, an increased rate of cell death, or both. Thy- 
mocytes from GR-TKO mice did in fact have an increased 
frequency of CD4+CD8+ cells undergoing seemingly spon- 
taneous apoptosis, suggesting that enhanced cell death 
is likely to account for at least some of the reduction in 
CD4+CD8+ cell number. Furthermore, the CD4+CD8+ cells 
from the transgenic mice were abnormally sensitive to anti- 
TCR-mediated deletion. The mechanism responsible for 
this enhanced sensitivity is not clear at this time. It is pos- 
sible that steroids normally potentiate the expression of 
putative “survival” factors such as Bcl-x (Ma et al., 1995). 
Alternatively, glucocorticoids are known to inhibit the acti- 
vation-induced expression of FasL, a molecule involved 
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in the activation-induced apoptosis of peripheral T cells 
(Yang et al., 1995). While it does not appear that Fas is 
directly involved in negative selection of thymocytes, it is 
possible that steroids could inhibit the expression of other 
FasL family members that may be involved in the activa- 
tion-induced death of thymocytes. Whatever the cause, 
it seems likely that at least some of the increase in the 
spontaneous rate of apoptosis observed in thymocytes 
from GR-TKO +I+ mice is due to engagement of TCRs with 
endogenous ligands that, under normal circumstances, do 
not cause apoptosis. Since an accumulation of neglected 
CD4+CD8+ thymocytes expressing abnormally low levels 
of TCR were not observed in GR-TKO +I+ mice, it is likely 
that redundant pathways exist that limit the lifespan of 
neglected thymocytes in the absence of TCR engagement 
(Zhou et al., 1993). 
While antigen-specific deletion may be responsible for 
at least a portion of the decrease in cell number in GR-TKO 
+I+ thymi, it is unlikely to account for all of it. Although 
the actual numbers are not known, studies examining 
apoptosis in major histocompatibility complex-deficient 
mice suggest that only a small fraction of the apoptosis 
observed in the thymus is due to negative selection (Surh 
and Sprent, 1994) and a comparably small number of 
thymocytes are thought to undergo positive selection 
(Rothenberg, 1992). Since thymocyte recovery from GR- 
TKO+/+ mice is approximately 10% of nontransgenic con- 
trol animals, it is unlikely that the enhanced death of the 
fraction of thymocytes engaged in TCR-mediated signal- 
ing events could account for this decrease. Indeed, analy- 
sis of thymocyte development during fetal ontogeny re- 
vealed another potentially steroid-responsive stage of 
thymocyte maturation. During fetal development, the num- 
ber of thymocytes recovered from GR-TKO+/+ mice and 
nontransgenic mice were identical on fetal day 15 but 
down - 50% on fetal day 16. Between day 15 and day 
16 of fetal development, thymocytes enter a proliferative 
stage, down-regulate CD25 expression, and begin to tran- 
sit from the CD4CD8- to the CD4+CD8+ stage (Rothen- 
berg, 1992). During this transitional phase there is little 
if any expression of antigen-specific a6 TCRs, making it 
highly unlikely that the decrease in cell recovery on day 16 
is an antigen-specific event (Rothenberg, 1992; Andjelic 
et al., 1993; Groettrup and von Boehmer, 1993). While 
thymocytes from GR-TKO+/+ mice have a normal pheno- 
type with regard to the CD44- and CD25-bearing subsets, 
expansion of the cells at this transition point appears to 
be reduced and the generation of CD4CD8’ cells is ineffi- 
cient. Thus, it appears that steroid stimulation is required 
for normal progression of CD4-CD8- to CD4+CD8+ cells. 
The requirement for glucocorticoid stimulation during 
the expansion and transitional phase of thymocyte devel- 
opment is reminiscent of the highly temporalized expres- 
sion of steroid-responsive genes encoding crucial en- 
zymes during liver and retinal organogenesis (Cole et al., 
1993; Ben-Dror et al., 1993; Zhang et al., 1993). It is possi- 
ble that the requirement for glucocorticoids in thymocyte 
development also reflects the need for such molecules. 
Consistent with this, lethal mutant albino mice deficient 
in their ability to up-regulate hepatic enzymes in asteroid- 
responsive fashion have abnormally small thymi (De- 
Franc0 et al., 1991; Erickson et al., 1968). Alternatively, 
inefficient progression to the CD4+CD8+ stage may reflect 
a more immunologically relevant developmental abnor- 
mality in GR-TKO +/+ mice. The acquisition of large num- 
bers of CD4+CD8+ cells depends upon expression of the 
pre-TCR, which consistsof pre-TCRa, TCR8, and the CD3 
chains (Groettrup et al., 1993; Saint-Ruf et al., 1994). Per- 
turbation of the pre-TCR with antibodies results in calcium 
mobilization (Levelt et al., 1993a; Groettrup et al., 1992) 
and promotes the progression of CD4CD8- to CD4+CD8+ 
cells in vitro (Levelt et al., 1993b). Thymocytes from day 
15 fetal mice express TCRp protein (Levelt et al., 1993a) 
and pre-TCRa mRNA (as assessed by RT-PCR, unpub- 
lished data). Therefore, one possible explanation for the 
effect of the antisense GR transgene on CD4+CD8+ devel- 
opment is that, as for signaling via the a8 TCR, signaling 
via the pre-TCR may lead to cell death in the absence of 
glucocorticoid-mediated antagonism. Although the data in 
this report do not allow us to determine the mechanism 
of glucocorticoid action at this developmental stage, we 
are currently examining the generation of CD4+CD8+ cells 
that occurs in a pre-TCR-independent manner. CD4+CD8+ 
cells do not develop in RAG-deficient mice because they 
cannot rearrange the TCR6 chain. However, expression 
of a constitutively active form of Lck in these mice allows 
CD4+CD8+ cells to develop, even in the absence of the 
pre-TCR (Mombaerts et al., 1994). Determining the effect 
of the antisense GR transgene on CD4CD8’ cell produc- 
tion in these mice might provide insight into the mecha- 
nism by which glucocorticoids facilitate T cell development. 
Experimental Procedures 
Generation of Transgenic Mice 
The Ick-AGR plasmid utilized for generating the transgenic mice was 
constructed by subcloning an 1800 bp Pstl-Xbal fragment from the 
pSG1 vector (Miesfeld et al., 1984) containing the untranslated region 
of the rat GR into pBluescript II KS (Stratagene, La Jolla, California). 
The Xhol-Xbal fragment was excised and blunt-end cloned into the 
BamHl site of the ~1017 expression vector containing the Ick proximal 
promoter (Chaffin et al., 1990). A Notl fragment containing the se- 
quence of interest was excised and injected into the pronucleus of 
(C57BU6 x DBA/2)F2 single cell embryos as described (Hunziker 
and Margulies, 1991). 
Northern Blot Analysis 
RNA was extracted from the indicated tissues of nontransgenic -/- 
or GR-TKO +I+ mice using RNA-STAT-60 (Tel-Test B, Incorporated, 
Friendswood, Texas). Total RNA (10 ug) was subjected to Northern 
blot analysis on a 1% agaroselformaldehyde gel. The RNA was trans- 
ferred to Hybond-N (Amersham, Arlington Heights, Illinois) by capillary 
action and probed with the Pstl-Xbal fragment of pSG-1 containing 
the 3’ untranslated region of the rat GR (Miesfeld et al., 1984) or a 
Pst fragment from the coding region of the mouse GR (Danielsen et 
al., 1986) after labeling and hybridization with the Prime-It II kit and 
QuikHyb, according to the instructions of the manufacturer (Stra- 
tagene, La Jolla, California). 
lmmunoblot Analysis 
Cytoplasmic extracts were prepared from thymocytes by resuspension 
in extraction buffer (Schreiber et al., 1989) and lysing in 0.5% NP-40. 
Equivalent amounts of cytoplasmic protein (46 ng for GR blot, 83 pg 
for Lck blot) were electrophoresed on a 9% SDS-polyacrylamide gel. 
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After transfer, the blots were probed with either the monoclonal anti-GR 
antibody, BUGR-2 (Affinity BioReagents, Neshanic Station, New Jer- 
sey) or the anti-Lck rabbit antiserum 688 (a gift of Dr. L. Samelson, 
National institute of Child Health and Human Development, National 
Institutes of Health), followed by ‘“l-protein A (ICN, Costa Mesa, Cali- 
fornia) as described (Volarevic et al., 1992). 
Transient Transfection of Thymocytes 
Thymocytes from nontransgenic -I- or GR-TKO +I+ mice were pooled 
and electroporated (4.25 x IO’ cells/O.25 mllcuvette, 330 V, 960 nF, 
using a Bio-Rad Gene Pulser) in Iscove’s medium containing 10% 
fetal calf serum. Cells were transfected with 15 pg of a glucocorticoid- 
responsive luciferase expression construct, GRE-LUC, driven by a 
thymidine kinase basal promoter and two copies of a consensus GRE 
(AGC Tl-f GTA CAG GAT GTT CTA GTC TAG ATG TAC AGG ATG 
TTC TG) and 1 ug of a CMV+galactosidase construct as an indicator 
of transfection efficiency. Multiple cuvettes were pooled and plated in 
duplicate, cultured for 1 hr in the absence of corticosterone. and then 
cultured with or without the indicated concentrations of corticosterone 
for 5 hr. Cell lysates were divided and assayed for luciferase and 
j3-galactosidase activity according to the instructions of the manufac- 
turer (Promega, Madison, Wisconsin), and relative light units were 
quantitated with a luminometer (Monolight 2010, Analytical Lumines- 
cence Lab, San Diego, California). 
Steroid Sensitivity 
Thymocytes from individual mice were placed in suspension culture 
with the indicated concentrations of corticosterone. After 11 hr, cells 
were harvested and stained with phycoerythrin-conjugated anti-CD4 
and fluorescein-conjugated anti-CD6 antibodies (Pharmingen, San 
Diego, California). Propidium iodide (PI) (10 uglml) was added to iden- 
tify dead or dying cells, and the cells were analyzed by flow cytometry 
on the FACScan (Becton Dickinson, Mountain View, California). After 
analysis, gates were set around the CD4’CDb cells and the percent- 
age of cells staining with PI was determined. 
Apoptosls assay 
Thymocytes from nontransgenic -I- and GR-TKO +I+ mice were form- 
aldehyde-fixed, permeabilized with either methanol or 0.1% Triton 
X-100/ 0.1% sodium citrate, and subjected to a modified in situ nick 
translation assay using fluorescein-dUTP and DNA polymerase 
(Boehringer-Mannheim, Indianapolis, Indiana) (Gold et al., 1993). In 
brief, l-2 x lo8 cells were incubated in nick translation buffer (50 
mM Tris [pH 7.51, 10 mM MgSO,, 0.1 mM DTT) with 1 nmol each 
dATP, dCTP, and dGTP, 0.7 nmol dlTP. 0.3 nmol fluorescein-dUTP, 
and 5 U DNA polymerase for 2 hr at 37% Cells were then either 
visualized by fluorescence microscopy or analyzed by flow cytometry 
on the FACScan (Becton Dickinson, Mountain View, California). This 
assay specifically detected apoptotic cells, because the same tech- 
nique did not label proliferating T hybridoma cells unless they were 
cultured with a lethal concentration of corticosterone (data not shown). 
Fetal Thymic Organ Culture 
Fetuses were obtained from 12 hr timed pregnant.mice mated in our 
animal facility. The day of the vaginal plug was considered day 0. For 
day 14 fetuses, thymi were cultured in the presence of 225 uglml 
metyrapone or ethanol control with or without corticosterone for 6 days. 
Thymic lobes were placed on Millipore filters floating on a gelfoam 
sponge in complete serum-free HL-1 medium as described (Vacchio 
et al., 1994). All cultures were carried out in 1.5 ml of media per well 
in 12-well plates. Medium was changed every 2 days and new metyra- 
pone or ethanol control with or without corticosterone was added. At 
the end of the 8 day culture, single cell suspensions were prepared 
for counting and stained for analysis by flow cytometry. For the H57- 
sensitivity assays, individual lobes from fetal thymi (day 17.5) were 
cultured for 24 hr in Iscove’s medium supplemented with 10% fetal calf 
serum, 1 mM sodium pyruvate, nonessential amino acids (BioFluids. 
Rockville, Maryland), 4 mM glutamine, 50 utM f%mercaptoethanol, and 
antibiotics as described (Vacchio et al., 1994). Lobes were teased 
apart, viable cells counted in the presence of trypan blue, and the 
fraction of cellsthat wereThy-l+CD4+CDB+wasdetermined by staining 
with fluoresceinated 30H.12, phycoery-thrin-conjugated antiCD4, and 
biotin-conjugated anti-CD8 (detected with Cychrome avidin) antibod- 
ies (Pharmingen, San Diego, California). 
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